Related Experiment Videos
Carrier detection in Sandhoff disease.
American Journal of Human Genetics
|January 1, 1978
Summary
Sandhoff disease carrier detection is improved by measuring both total and heat-stable hexosaminidase enzyme activity. This method identified carriers in an isolated community and among Ashkenazi Jews, aiding genetic screening.
Area of Science:
- Biochemistry
- Genetics
- Medical Research
Background:
- Sandhoff disease is a rare, fatal neurodegenerative lysosomal storage disorder.
- Accurate carrier identification is crucial for genetic counseling and reproductive planning.
- Previous screening methods may not be sufficient for detecting all Sandhoff disease carriers.
Observation:
- Three new cases of Sandhoff disease were reported, including an infant from an isolated community.
- Enzyme assays on 38 relatives revealed two distinct cohorts: carriers with low total and heat-stable hexosaminidase, and unaffected individuals.
- A retrospective study identified six Sandhoff carriers among over 14,000 Ashkenazi Jews screened for Tay-Sachs disease.
Findings:
- Carrier status for Sandhoff disease was diagnosed by measuring both total and heat-stable hexosaminidase enzyme activity.
- Sixteen individuals from the kindred were identified as carriers, demonstrating the effectiveness of the dual assay.
- The study confirmed the utility of this diagnostic approach in diverse populations, including isolated communities and Ashkenazi Jews.
Implications:
- Measuring both total and heat-stable hexosaminidase activity is essential for accurate Sandhoff disease carrier detection.
- This improved screening strategy can enhance genetic counseling and family planning for affected kindreds and at-risk populations.
- Further research may refine carrier screening protocols for lysosomal storage diseases.